Skip to main content
. 2018 Nov 15;2018(11):CD003402. doi: 10.1002/14651858.CD003402.pub3

Valentine 2014.

Methods RCT
Participants 90 pregnant women (19‐20 weeks GA); > 18 years; diagnosed with hypertension; without bleeding disorders, lupus, autoimmune diseases, or presence of infant congenital (trisomy 13, 18, 21, urethral, gastrointestinal and cardiac defects)
Interventions 1) 200 mg DHA daily, from 18‐20 weeks GA to 6 weeks postpartum
2) 1000 mg DHA daily, from 18‐20 weeks GA to 6 weeks postpartum
Outcomes Primary: endothelial health (measures not reported); secondary: maternal homoeostasis (blood and cord blood concentrations of pro‐inflammatory cytokines IL‐6, I L‐8, TNF a, and receptor sRAGE
Notes May have been withdrawn/never commenced